Medicare Enrolled
Dr. Jean-Raphael Schneider, M.D.
Neurology · Clearwater, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Schneider from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schneider?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Schneider
Dr. Jean-Raphael Schneider is a neurology specialist in Clearwater, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Schneider performed 42,612 Medicare services across 2,035 unique beneficiaries.
Between the years covered by Open Payments, Dr. Schneider received a total of $240,090 from 94 pharmaceutical and/or device companies across 1579 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Schneider is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 2% volume in FL
$240,090 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 96249 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗42,612
Medicare services
Top 2% in FL for neurology
2,035
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,243 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
22,001 | $5 | $13 |
| Ocrelizumab infusion (Ocrevus) for MS | 16,800 | $42 | $165 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
648 | $90 | $164 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
548 | $75 | $142 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
507 | $16 | $73 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
485 | $130 | $220 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
277 | $49 | $233 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
203 | $99 | $472 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
183 | $162 | $350 |
| New patient office visit, complex (60-74 min) | 161 | $164 | $314 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
122 | $140 | $310 |
| Nerve conduction studies, 11-12 A diagnostic test that measures how well nerves send electrical signals. It involves performing 11 to 12 separate nerve conduction studies. |
108 | $187 | $394 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
92 | $95 | $159 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
81 | $109 | $238 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
62 | $12 | $55 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
60 | $4 | $18 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
59 | $20 | $101 |
| Assessment of emotional or behavioral problems An evaluation to identify and understand emotional or behavioral issues. This process involves reviewing symptoms and behaviors to determine the nature of the concerns. |
52 | $3 | $25 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
45 | $63 | $111 |
| Needle measurement of electrical activity in muscle with injection of chemical for paralysis of nerve muscle | 39 | $60 | $114 |
| Injection of anesthetic or steroid into upper neck and back of head nerve An injection of an anesthetic agent and/or steroid into a nerve located in the upper neck and back of the head. |
27 | $67 | $129 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
26 | $115 | $249 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
26 | $174 | $423 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.7% high complexity
52.4% medium
5.9% routine
Industry Payment Transparency
Open Payments through 2024 ↗$240,090
Total received (2018-2024)
Avg $34,299/year across 7 years
Top 3% in FL for neurology
94
Companies
1,579
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$189,137 (78.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$26,733 (11.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$24,220 (10.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$24,263
2023
$16,837
2022
$24,018
2021
$15,732
2020
$17,205
2019
$80,515
2018
$61,520
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
GENZYME CORPORATION
$64,604
Alexion Pharmaceuticals, Inc.
$48,144
Genentech USA, Inc.
$46,136
ARGENX US, INC.
$19,011
EMD Serono, Inc.
$17,009
E.R. Squibb & Sons, L.L.C.
$14,420
Celgene Corporation
$5,765
Novartis Pharmaceuticals Corporation
$2,663
Biogen, Inc.
$2,329
UCB, Inc.
$1,551
Alnylam Pharmaceuticals Inc.
$1,397
Janssen Scientific Affairs, LLC
$1,391
Genentech, Inc.
$1,310
Lilly USA, LLC
$854
ABBVIE INC.
$839
Avanir Pharmaceuticals, Inc.
$752
Allergan, Inc.
$723
Amgen Inc.
$722
Lundbeck LLC
$639
AbbVie Inc.
$598
Teva Pharmaceuticals USA, Inc.
$510
Janssen Pharmaceuticals, Inc
$478
Horizon Therapeutics plc
$467
PFIZER INC.
$433
Takeda Pharmaceuticals U.S.A., Inc.
$398
Allergan Inc.
$347
CSL Behring
$327
Supernus Pharmaceuticals, Inc.
$301
TG Therapeutics, Inc.
$293
ARBOR PHARMACEUTICALS, INC.
$292
BANNER LIFE SCIENCES, LLC
$291
Eisai Inc.
$288
Otsuka America Pharmaceutical, Inc.
$283
UPSHER-SMITH LABORATORIES LLC
$264
IMPEL PHARMACEUTICALS INC.
$258
Biohaven Pharmaceuticals, Inc.
$230
GE HEALTHCARE
$212
SANOFI-AVENTIS U.S. LLC
$207
Azurity Pharmaceuticals, Inc.
$183
MITSUBISHI TANABE PHARMA AMERICA, INC.
$166
Acorda Therapeutics, Inc
$155
Upsher-Smith Laboratories LLC
$143
TG THERAPEUTICS, INC.
$135
Neurocrine Biosciences, Inc.
$135
Merz Pharmaceuticals, LLC
$133
Merz North America, Inc.
$128
Grifols USA, LLC
$118
JAZZ PHARMACEUTICALS INC.
$104
Arbor Pharmaceuticals, Inc.
$104
Mitsubishi Tanabe Pharma America, Inc.
$99
ACADIA Pharmaceuticals Inc
$95
Mallinckrodt LLC
$90
CATALYST PHARMACEUTICALS, INC.
$88
Octapharma USA, Inc.
$87
Biohaven Pharmaceutical Holding Company Ltd.
$87
Banner Life Sciences, LLC
$83
Mallinckrodt Hospital Products Inc.
$81
Amylyx Pharmaceuticals, Inc.
$70
EISAI INC.
$66
Sobi, Inc
$63
Collegium Pharmaceutical, Inc.
$59
IDORSIA PHARMACEUTICALS US INC
$56
Bayer HealthCare Pharmaceuticals Inc.
$54
Nevro Corp.
$51
Bausch Health US, LLC
$48
Sandoz Inc.
$48
Amneal Pharmaceuticals LLC
$44
Currax Pharmaceuticals LLC
$41
Xeris Pharmaceuticals, Inc.
$38
Vanda Pharmaceuticals Inc.
$36
Catalyst Pharmaceuticals, Inc.
$36
GE Healthcare
$28
SK Life Science, Inc.
$25
Mallinckrodt Enterprises LLC
$24
Akcea Therapeutics, Inc.
$24
Vertical Pharmaceuticals, LLC
$23
Cycle Pharmaceuticals Inc
$23
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
Exeltis, USA Inc.
$21
AstraZeneca Pharmaceuticals LP
$21
Ultragenyx Pharmaceutical Inc.
$21
ASSERTIO THERAPEUTICS, Inc.
$19
GE HealthCare
$17
Medtronic USA, Inc.
$17
Sarepta Therapeutics, Inc.
$17
Egalet US Inc
$17
Averitas Pharma Inc.
$16
Zyla Life Sciences, Inc.
$15
Shire North American Group Inc
$14
Becton, Dickinson and Company
$14
Purdue Pharma L.P.
$13
Almatica Pharma LLC
$13
Assertio Therapeutics, Inc.
$13
Merck Sharp & Dohme Corporation
$12
Top 3 companies account for 66.2% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AIMOVIG · AJOVY · AMPYRA · AMVUTTRA · AMYVID · AUBAGIO · Aimovig · BAFIERTAM · BELSOMRA · BOTOX · BOTOX THERAPEUTIC · BRIUMVI · Bard Urinary Drainage Bag · Betaseron · Briviact · COMIRNATY · CONTRAVE · COPAXONE · Cambia · DUOPA · Dayvigo · ELYXYB - celecoxib · EMGALITY · EVUSHELD · Elevidys · Enspryng · Erivedge · Evrysdi · FIRDAPSE · Fycompa · GAMMAGARD · GILENYA · GIVLAARI · GRALISE · GVOKE PFS · Gamunex-C · HORIZANT · HYQVIA · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · LEMTRADA · LYVISPAH · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · NORTHERA · NUEDEXTA · NUPLAZID · NURTEC ODT · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONPATTRO · OXTELLAR XR · Ocrevus · Omnia · Ozanimod · PANZYGA · PAXLOVID · PIPELINE-MS · POMPE - DISEASE · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · QULIPTA · QUTENZA · QUVIVIQ · RADICAVA · RELEXXII · RELISTOR · RELYVRIO · REXULTI · REYVOW · Radicava · Rebif · Rystiggo · SOLIRIS · SPINRAZA · SPRIX · SUNOSI · SYNCHROMED · Senza · Soliris · TECFIDERA · TEGSEDI · TEPEZZA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Tascenso ODT · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · XCOPRI · XEOMIN · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZOMIG · Zilbrysq
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for neurology in FL.
Equivalent to $563 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
172
Per 100K population
17.9
County median income
$70,293
Nearest hospital
MEASE COUNTRYSIDE HOSPITAL
2.8 mi
2.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Schneider is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), with speaking/promotional industry engagement in the top 3% of FL peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Schneider experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Schneider performed 22,001 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Schneider receive payments from pharmaceutical companies?
Yes. Dr. Schneider received a total of $240,090 from 94 companies across 1,579 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schneider's costs compare to other neurologists in Clearwater?
Dr. Schneider's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schneider) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Clearwater
Browse neurologists in Clearwater ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in FL
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in FL
Which FL neurologists receive the most from drug and device companies.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology